Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
00597-0197-05 - idaruCIZUmab 2.5 g/50 mL [NCTY] (CDM 9821367) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved October 12, 2026 , from http://ppman.hank.ai/transparency/procedure/9821367/by-state?code_type=CDM
“00597-0197-05 - idaruCIZUmab 2.5 g/50 mL [NCTY] (CDM 9821367) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/9821367/by-state?code_type=CDM. Accessed
October 12, 2026 .
“00597-0197-05 - idaruCIZUmab 2.5 g/50 mL [NCTY] (CDM 9821367) by State,” HANK Price Transparency ,
accessed October 12, 2026 ,
http://ppman.hank.ai/transparency/procedure/9821367/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
9821367 — 00597-0197-05 - idaruCIZUmab 2.5 G/50 Ml [ncty]
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$5,430
National median
$2,526 – $5,812
IQR (p25 – p75)
1
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 9821367 (CDM), with interquartile range
State Median p25 p75
VT $5,430 $2,526 $5,812